Lipella Pharmaceuticals Inc (NASDAQ:LIPO) has a beta value of 0.32 and has seen 2.52 million shares traded in the recent trading session. The company, currently valued at $5.38M, closed the recent trade at $2.11 per share which meant it lost -$0.17 on the day or -7.46% during that session. The LIPO stock price is -468.72% off its 52-week high price of $12.00 and 6.64% above the 52-week low of $1.97. If we look at the company’s 10-day average daily trading volume, we find that it stood at 33940.0 shares traded. The 3-month trading volume is 2.17 million shares.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO) trade information
Sporting -7.46% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the LIPO stock price touched $2.11 or saw a rise of 14.92%. Year-to-date, Lipella Pharmaceuticals Inc shares have moved -30.82%, while the 5-day performance has seen it change -13.88%. Over the past 30 days, the shares of Lipella Pharmaceuticals Inc (NASDAQ:LIPO) have changed -18.53%. Short interest in the company has seen 20718.0 shares shorted with days to cover at 0.43.
Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could drop -5.5% from the levels at last check today.. The projected low price target is $2.0 while the price target rests at a high of $2.0. In that case, then, we find that the latest price level in today’s session is 5.21% off the targeted high while a plunge would see the stock lose 5.21% from the levels at last check today..
Lipella Pharmaceuticals Inc (LIPO) estimates and forecasts
The company’s shares have lost -41.69% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -100.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -122.94% over the past 5 years.
LIPO Dividends
Lipella Pharmaceuticals Inc is expected to release its next earnings report on 2025-Mar-27 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s Major holders
Insiders own 9.05% of the company shares, while shares held by institutions stand at 2.89% with a share float percentage of 3.18%. Investors are also buoyed by the number of investors in a company, with Lipella Pharmaceuticals Inc having a total of 4.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.17% shares in the company for having 4.31 shares of worth $9059.0 while later fund manager owns 3.06 shares of worth $6417.0 as of Feb 28, 2025 , which makes it owner of about 0.12% of company’s outstanding stock.
